RS11057830 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:None]"
GWAS Studies (17)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Coronary artery disease | A | β: 0.082 | 3E-20 | PubMed |
| Coronary artery disease | A | β: 0.066 | 2E-18 | PubMed |
| Low density lipoprotein cholesterol levels | — | β: 0.03 | 2E-15 | PubMed |
| Coronary artery disease or fibrinogen levels (pleiotropy) | — | — | 6E-12 | PubMed |
| Coronary artery disease or factor VIII levels (pleiotropy) | — | — | 7E-12 | PubMed |
| Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | — | — | 8E-12 | PubMed |
| Coronary artery disease or tissue plasminogen activator levels (pleiotropy) | — | — | 8E-12 | PubMed |
| Coronary artery disease or factor VII levels (pleiotropy) | — | — | 8E-12 | PubMed |
| Coronary artery disease or von Willebrand factor levels (pleiotropy) | — | — | 8E-12 | PubMed |
| Coronary artery disease or factor XI levels (pleiotropy) | — | — | 8E-12 | PubMed |
| Heart failure (MTAG) | A | OR: 6.46 | 1E-10 | PubMed |
| Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | A | OR: 1.07 | 4E-9 | PubMed |
| Lipoprotein phospholipase A2 activity in cardiovascular disease | A | OR: 3.67 | 7E-9 | PubMed |
| Vitamin E levels | A | β: 0.03 | 8E-9 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | A | β: 0.046 | 2E-8 | PubMed |
| X-11308 levels | A | β: 0.082 | 2E-8 | PubMed |
| Coronary artery disease (confirmatory factor analysis Factor 16) | — | — | 5E-8 | PubMed |